Genetics and molecular biology controversies on Mendelian randomization and proprotein convertase subtilisin–kexin type 9 inhibitor clinical trials: more data still necessary

    loading  Checking for direct PDF access through Ovid

Abstract

Abstract unavailable for this article.

Related Topics

    loading  Loading Related Articles